Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis

Lauer EM, Waterhouse M, Braig M, Mutter J, Bleul S, Duque-Afonso J, Duyster J, Marks R, Reinacher PC, Prinz M, Illerhaus G, Finke J, Schorb E, Scherer F.

Br J Haematol.                online article

In this single-centre case series, we report the results of a retrospective real-world analysis of rrCNSL patients treated with either off-label ibrutinib monotherapy or ibrutinib based combination therapy.